Zomedica Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.02	7.02	12.95	27.4	194.95
Short-Term Investments	44.24	64.33	77.55	87.69	-
Cash & Short-Term Investments	53.26	71.35	90.5	115.09	194.95
Cash Growth	-25.36%	-21.15%	-21.37%	-40.96%	214.48%
Accounts Receivable	3.01	2.42	1.2	0.6	0.32
Other Receivables	0.44	0.65	1	1.27	0.45
Receivables	3.46	3.07	2.2	1.86	0.77
Inventory	5.55	5.06	5.12	2.75	2.85
Prepaid Expenses	1.79	2.29	2.06	3.8	1.84
Total Current Assets	64.04	81.77	99.88	123.5	200.41
Property, Plant & Equipment	22.94	26.2	25.29	9.17	2.87
Long-Term Investments	-	-	10.01	40.71	-
Goodwill	-	45.56	61.58	63.98	43.29
Other Intangible Assets	38.81	52.54	55.36	41.8	33.18
Other Long-Term Assets	1.25	1.29	1.07	0.45	0.66
Total Assets	127.04	207.36	253.2	279.61	280.4
Accounts Payable	1.72	1.93	2.07	6.7	3.23
Accrued Expenses	6.2	6.1	5.35	-	-
Current Portion of Leases	0.72	0.52	0.92	0.64	0.42
Current Income Taxes Payable	0.25	0.12	0.07	0.19	0.24
Current Unearned Revenue	0.37	0.33	0.28	0.21	0.2
Other Current Liabilities	0.2	0.34	0.36	0.08	0.26
Total Current Liabilities	9.45	9.33	9.03	7.81	4.34
Long-Term Leases	1.47	1.29	1.81	1.1	0.96
Long-Term Unearned Revenue	0.23	0.22	0.25	0.18	0.14
Long-Term Deferred Tax Liabilities	0.03	0.46	1.14	1.25	3.71
Other Long-Term Liabilities	0.47	0.4	0.94	1.88	0.36
Total Liabilities	11.64	11.7	13.18	12.22	9.51
Common Stock	380.97	380.97	380.97	380.97	380.96
Additional Paid-In Capital	34.04	32.52	29.93	23.67	9.31
Retained Earnings	-299.77	-217.92	-170.93	-136.4	-119.39
Comprehensive Income & Other	0.16	0.09	0.05	-0.84	0
Total Common Equity	115.4	195.66	240.02	267.39	270.89
Shareholders' Equity	115.4	195.66	240.02	267.39	270.89
Total Liabilities & Equity	127.04	207.36	253.2	279.61	280.4
Total Debt	2.18	1.81	2.73	1.74	1.38
Net Cash (Debt)	51.07	69.54	87.77	113.35	193.57
Net Cash Growth	-26.56%	-20.77%	-22.57%	-41.44%	221.96%
Net Cash Per Share	0.05	0.07	0.09	0.12	0.20
Filing Date Shares Outstanding	979.95	979.95	979.95	979.95	979.9
Total Common Shares Outstanding	979.95	979.95	979.95	979.95	979.9
Working Capital	54.59	72.44	90.85	115.69	196.07
Book Value Per Share	0.12	0.20	0.24	0.27	0.28
Tangible Book Value	76.59	97.57	123.07	161.61	194.42
Tangible Book Value Per Share	0.08	0.10	0.13	0.16	0.20
Machinery	16.57	17.03	10.44	6.85	1.73
Construction In Progress	6.42	7.89	12.48	0.69	0.42
Leasehold Improvements	2.85	3.09	1.95	1.24	0.29

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.